Clinical Trial

A Prospective, Single-center, Observational Study Aiming to Assess the Predictive Role of Flow Mediated Dilatation in Acute Coronary Syndromes, Combined With Echocardiographic and Biochemical Indices

Study acronym: FLARE-ACS
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 2, 2026 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
A prospective, single-center, observational study aiming to assess the predictive role of flow mediated dilatation in acute coronary syndromes, combined with echocardiographic and biochemical indices. The novel Cor-IS technology will also be evaluated.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-03-20; most recent amendment 2026-02-27.
Status change: Active, Not Recruiting → Recruiting 2025-04-28
Trial Details
NCT Number NCT06890013
Lead Sponsor Aristotle University Of Thessaloniki
Conditions Acute Coronary Syndromes, Flow Mediated Dilation, Endothelial Function (FMD)
Enrollment 100 participants
Start Date 2024-06-01
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-11-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-02